Mometasone Furoate Lotion Once Daily Versus Triamcinolone Acetonide Lotion Twice Daily in Psoriasis
1989; Wiley; Volume: 28; Issue: 10 Linguagem: Inglês
10.1111/j.1365-4362.1989.tb02442.x
ISSN1365-4632
AutoresJames M. Swinehart, Joel R. Barkoff, Danie Dvorkin, George A. Fisher, Edwin A. Peets,
Tópico(s)Dermatology and Skin Diseases
ResumoInternational Journal of DermatologyVolume 28, Issue 10 p. 680-681 Mometasone Furoate Lotion Once Daily Versus Triamcinolone Acetonide Lotion Twice Daily in Psoriasis James M. Swinehart M.D., Corresponding Author James M. Swinehart M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseyAddress for correspondence: lames M. Swinehart, M.D., Colorado Medical Research Center, Suite 630, Harvard Park Medical Plaza, 950 E. Harvard Avenue, Denver, CO 80210.Search for more papers by this authorJoel R. Barkoff M.D., Joel R. Barkoff M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this authorDanie1 Dvorkin M.D., Danie1 Dvorkin M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this authorGeorge Fisher M.D., George Fisher M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this authorEdwin Peets Ph.D., Edwin Peets Ph.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this author James M. Swinehart M.D., Corresponding Author James M. Swinehart M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseyAddress for correspondence: lames M. Swinehart, M.D., Colorado Medical Research Center, Suite 630, Harvard Park Medical Plaza, 950 E. Harvard Avenue, Denver, CO 80210.Search for more papers by this authorJoel R. Barkoff M.D., Joel R. Barkoff M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this authorDanie1 Dvorkin M.D., Danie1 Dvorkin M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this authorGeorge Fisher M.D., George Fisher M.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this authorEdwin Peets Ph.D., Edwin Peets Ph.D. From the Colorado Medical Research Center, Denver, Colorado; Albuquerque Dermatology Associates, Albuquerque, New Mexico; Brandywine Hospital, Coatesville, Pennsylvania; Department of Dermatology, West Florida Regional Hospital, Pensacola, Florida; Schering-Plough Corporation, Kenilworth, New JerseySearch for more papers by this author First published: December 1989 https://doi.org/10.1111/j.1365-4362.1989.tb02442.xCitations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Medansky RS, Bressinck R, Cole GW, et al.: Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: Comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent. Cutis. 1988; 42: 480– 485. 2 Medansky RS, Brody MI, Kanof NB, et al.: Clinical investigations of mometasone furoate—a novel, nonfluorinated, topical corticosteroid. Semin Dermatol. 1987; 6: 94– 100. 3 Bressinck R, Williams J, Peets E.: Comparison of the effect of mometasone furoate ointment 0.1%, and hydrocortisone ointment 1%, on adrenocortical function in psoriasis patients. Today's Therapeutic Trends. 1988; 5: 25– 34. Citing Literature Volume28, Issue10December 1989Pages 680-681 ReferencesRelatedInformation
Referência(s)